Edition:
United States

Neuralstem Inc (CUR.OQ)

CUR.OQ on NASDAQ Stock Exchange Capital Market

1.88USD
2:54pm EST
Change (% chg)

$-0.05 (-2.59%)
Prev Close
$1.93
Open
$1.88
Day's High
$1.96
Day's Low
$1.77
Volume
101,386
Avg. Vol
204,705
52-wk High
$6.58
52-wk Low
$0.89

Select another date:

Mon, Nov 13 2017

BRIEF-Neuralstem Q3 loss per share $0.01

* Neuralstem reports third quarter 2017 fiscal results and provides clinical and business update

BRIEF-Neuralstem Inc appoints two members to its board

* Neuralstem announces the appointment of two new members to the board of directors

BRIEF-Neuralstem Inc gets two additional U.S. patents

* Neuralstem Inc - ‍been awarded two additional patents by United States Patent and Trademark Office​ Source text for Eikon: Further company coverage:

BRIEF-Neuralstem reports Q2 loss per share $0.39

* Neuralstem reports second quarter 2017 fiscal results and provides clinical and business update

BRIEF-‍CVI investments reports a 8.3 pct passive stake in Neuralstem

* ‍CVI Investments reports a 8.3 percent passive stake in Neuralstem Inc as of July 27, 2017 - SEC filing Source text: (http://bit.ly/2vbUBwE) Further company coverage:

BRIEF-Neuralstem awarded grant by NIH to continue preclinical research into treatment for diabetic neuropathy

* Neuralstem awarded $~1mm grant by NIH to continue preclinical research into the potential of nsi-189 for treatment of diabetic neuropathy Source text for Eikon: Further company coverage:

BRIEF-Neuralstem announces top-line phase 2 data of nsi-189 for major depressive disorder

* Neuralstem announces top-line phase 2 data of nsi-189 for major depressive disorder

Select another date: